Effects of MACC1 siRNA on biological behaviors of HeLa

被引:14
作者
Chai, Hongxia [1 ]
Yang, Yongxiu [2 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Lanzhou 730000, Gansu, Peoples R China
关键词
Cervical cancer; HeLa cell; Metastasis-associated in colon cancer 1; Small interfering RNA; MET; OVEREXPRESSION; METASTASIS; EXPRESSION;
D O I
10.1007/s00404-013-3126-z
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Metastasis-associated in colon cancer 1 (MACC1) has been shown to play a critical role in several types of cancer. The purposes of this study were to evaluate MACC1 expression in cervical cancer and determine role of MACC1 small interference RNA (siRNA) in the growth and progression of cervical cancer. Immunohistochemical analysis of MACC1 expression was performed in different cervical lesion tissues. siRNA knockdown of MACC1 was performed. Cytoskeletal staining, RT-PCR, Western blot technology, transwell migration, MTT, and flow cytometry were used for identification of the functional roles of MACC1 siRNA in HeLa cells. Immunohistochemistry demonstrated that MACC1 overexpression was detected in cervical cancer tissues. MACC1 siRNA transfection remarkably affected HeLa cell biological behaviors. Expression of MACC1 in HeLa cells was significantly down-regulated by MACC1 siRNA. In addition, knockdown of MACC1 in HeLa cells caused a significant decrease in cell proliferation or migration, and increased cell apoptosis rate. Flow cytometry showed that MACC1 siRNA may inhibit cell proliferation by interfering with cell mitosis and cell cycle progression. These results suggest that MACC1 is a novel biomarker for cervical cancer diagnosis and a target for therapeutic interventions. Decreasing MACC1 expression by siRNA may prove to be an effective genetic therapy strategy.
引用
收藏
页码:1271 / 1280
页数:10
相关论文
共 19 条
[1]  
[Anonymous], 2006, Comprehensive Cervical Cancer Control: A Guide to Essential Practice
[2]   Colon cancer metastasis: MACC1 and Met as metastatic pacemakers [J].
Arlt, Franziska ;
Stein, Ulrike .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (12) :2356-2359
[3]  
Armes JE, 1999, CANCER RES, V59, P2011
[4]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[5]   Targeting the Hepatocyte Growth Factor-cMET Axis in Cancer Therapy [J].
Blumenschein, George R., Jr. ;
Mills, Gordon B. ;
Gonzalez-Angulo, Ana M. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) :3287-3296
[6]   Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer [J].
Boardman, Lisa A. .
GENOME MEDICINE, 2009, 1
[7]  
Bouras T, 2001, CANCER RES, V61, P903
[8]   Human papillomavirus and cervical cancer [J].
Burd, EM .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :1-+
[9]  
Ferlay J., 2011, GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10
[10]  
Kokoszynska K, 2009, ACTA BIOCHIM POL, V56, P317